Position history for MARSHALL WACE, LLP's holdings in ESPERION THERAPEUTICS INC NE
MARSHALL WACE, LLP holds 7.1M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $19.4M as of 2026-Q1. The position was increased (+29.3% shares). ESPR represents 0.0% of MARSHALL WACE, LLP's portfolio.
Current Value
$19.4M
Current Shares
7.1M
Total Value Change
+$9.8M
Total Shares Change
+2.8M
Other major holders of ESPR: Pentwater Capital Management LP, WASATCH ADVISORS LP
Increased |
| 7.1M |
+29.3% |
| $19.4M |
| 0.0% |
| $2.91 |
36 |
| 2025-Q4 | Increased | 5.5M | +117.0% | $20.2M | 0.0% | $3.69 | 46 |
| 2025-Q3 | Decreased | 2.5M | -52.5% | $6.7M | 0.0% | $2.64 | 0 |
| 2025-Q2 | Increased | 5.3M | +46.2% | $5.2M | 0.0% | $0.99 | 37 |
| 2025-Q1 | New | 3.6M | - | $5.2M | 0.0% | $1.50 | 37 |
| 2024-Q4 | Exited | 0 | -100.0% | $0 | 0.0% | $2.15 | 0 |
| 2024-Q3 | Decreased | 3.1M | -28.1% | $5.1M | 0.0% | $1.68 | 0 |
| 2024-Q2 | Increased | 4.3M | +94.2% | $9.6M | 0.0% | $2.22 | 44 |